BBA
ACHN

Baker Bros. Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

Baker Bros. Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,095,359
Closed -$3.94M – 113
2019
Q3 		$3.94M Hold
1,095,359
– – 0.03% 69
2019
Q2 		$2.94M Hold
1,095,359
– – 0.02% 73
2019
Q1 		$3.24M Hold
1,095,359
– – 0.02% 69
2018
Q4 		$1.74M Sell
1,095,359
-544,589
-33% -$1.54M 0.01% 77
2018
Q3 		$6.04M Sell
1,639,948
-303,672
-16% -$905K 0.04% 66
2018
Q2 		$5.5M Sell
1,943,620
-913,017
-32% -$3.11M 0.04% 71
2018
Q1 		$10.6M Hold
2,856,637
– – 0.09% 56
2017
Q4 		$8.23M Buy
2,856,637
+1,000,000
+54% +$3.63M 0.07% 62
2017
Q3 		$8.34M Hold
1,856,637
– – 0.07% 58
2017
Q2 		$8.52M Hold
1,856,637
– – 0.07% 52
2017
Q1 		$7.82M Hold
1,856,637
– – 0.06% 54
2016
Q4 		$7.67M Sell
1,856,637
-618,878
-25% -$3.29M 0.08% 54
2016
Q3 		$20.1M Hold
2,475,515
– – 0.18% 33
2016
Q2 		$19.3M Hold
2,475,515
– – 0.2% 34
2016
Q1 		$19.1M Buy
2,475,515
+475,515
+24% +$3.48M 0.2% 34
2015
Q4 		$21.6M Hold
2,000,000
– – 0.18% 40
2015
Q3 		$13.8M Buy
2,000,000
+476,261
+31% +$3.88M 0.13% 54
2015
Q2 		$13.5M Buy
1,523,739
+1,309,502
+611% +$12.4M 0.12% 56
2015
Q1 		$2.11M Sell
214,237
-224,100
-51% -$2.8M 0.02% 103
2014
Q4 		$5.37M Hold
438,337
– – 0.05% 70
2014
Q3 		$4.38M Hold
438,337
– – 0.06% 66
2014
Q2 		$3.32M Hold
438,337
– – 0.04% 80
2014
Q1 		$1.44M Sell
438,337
-16,663
-4% -$58.3K 0.02% 93
2013
Q4 		$1.51M Hold
455,000
– – 0.02% 83
2013
Q3 		$1.37M Hold
455,000
– – 0.02% 74
2013
Q2 		$3.72M Buy
+455,000
New +$3.47M 0.07% 51

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baker Bros. Advisors's ACHN Position: Q4 2019 in Review

Baker Bros. Advisors sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 1,095,359 shares — an estimated $3.94M sold.

Baker Bros. Advisors first reported a position in ACHN in Q2 2013 and held it in 26 quarters. The position peaked at $21.6M in Q4 2015. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Baker Bros. Advisors reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Baker Bros. Advisors sold 1,095,359 Achillion Pharmaceuticals shares in Q4 2019, an estimated $3.94M.
  • Baker Bros. Advisors first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 26 quarters.
  • Baker Bros. Advisors's Achillion Pharmaceuticals position peaked at $21.6M in Q4 2015.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Baker Bros. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.